Search research articles
Contact Us
Filters
Showing results (501-510 of 643) with videos related to
Page
of 65
Sort By:
Cancer
|
October 18, 2021
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified
Luana G Sousa, Kaiwen Wang, Danice Torman, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Journal of Immunotherapy and Precision Oncology
|
November 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma
Mohamed A Gouda, Bettzy Stephen, Yanyan Tian, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Jonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller
Ana M Gonzalez-Angulo, Jennifer K Litton, Kristine R Broglio, et al.
Cancer
|
January 11, 2005
Breast conservation after neoadjuvant chemotherapy
Allen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Page
of 65
Search research articles
Search
Showing results (501-510 of 643) with videos related to
Sort By:
Page
of 65
Cancer
|
October 18, 2021
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified
Luana G Sousa, Kaiwen Wang, Danice Torman, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Journal of Immunotherapy and Precision Oncology
|
November 11, 2024
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma
Mohamed A Gouda, Bettzy Stephen, Yanyan Tian, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Jonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller
Ana M Gonzalez-Angulo, Jennifer K Litton, Kristine R Broglio, et al.
Cancer
|
January 11, 2005
Breast conservation after neoadjuvant chemotherapy
Allen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Page
of 65